Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Embrace the future of well-being and join the conversation around BPC-157
Stability is the second reason researchers favour this peptide
received advisory/consulting fees and/or other support from Altimmune, AstraZeneca, Bayer, Biomea, Boehringer Ingelheim, Carmot Therapeutics, Cytoki Pharma, Eli Lilly, Intercept, Janssen/Johnson & Johnson, Mannkind, Mediflix, Merck, Metsera, Novo Nordisk, Pharmaventures, Pfizer, Regeneron, Sanofi, Shionogi, Structure Therapeutics, Target RWE, Terns Pharmaceuticals, The Comm Group, Valeritas, WebMD and Zealand Pharma
Research shows that BPC 157 heightens the healing factor and ability of many different types of tissue, from muscle to tendons, and the nervous system
Starting BPC-157 too early can interfere with that process rather than accelerate it
US$ 21.41
US$ 29.67
US$ 20.77
US$ 29.00
US$ 26.26
US$ 27.11
